<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2017-3-20-24</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-1592</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>РОЛЬ СУПЕРОКСИДДИСМУТАЗЫ В РАЗВИТИИ ПОСЛЕОПЕРАЦИОННОЙ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ  С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ  СЕРДЦА</article-title><trans-title-group xml:lang="en"><trans-title>A ROLE OF SUPEROXIDE DISMUTASE IN DEVELOPMENT OF POST-OPERATION ATRIAL FIBRILLATION IN CORONARY HEART DISEASE  PATIENTS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рубаненко</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rubanenko</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, ассистент кафедры факультетской терапии</p></bio><email xlink:type="simple">olesya.rubanenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фатенков</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fatenkov</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук,  доцент,  заведующий  кафедрой   факультетской  терапии</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлунов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlunov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, доцент, заведующий кафедрой кардиологии и кардиохирургии ИПО, главный врач</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лимарева</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Limareva</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор биологических наук,  доцент, ведущий научный сотрудник Института экспериментальной медицины и биотехнологий</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Самарский  государственный   медицинский  университет; Самарский областной  клинический кардиологический диспансер</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara   State  Medical  University; Samara Regional Clinical Cardiological Dispensary</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Самарский  государственный   медицинский  университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara   State  Medical  University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>25</day><month>03</month><year>2017</year></pub-date><volume>0</volume><issue>3</issue><fpage>20</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рубаненко О.А., Фатенков О.В., Хохлунов С.М., Лимарева Л.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Рубаненко О.А., Фатенков О.В., Хохлунов С.М., Лимарева Л.В.</copyright-holder><copyright-holder xml:lang="en">Rubanenko O.A., Fatenkov O.V., Khokhlunov S.M., Limareva L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/1592">https://russjcardiol.elpub.ru/jour/article/view/1592</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить уровень супероксиддисмутазы (СОД) у больных ишемической болезнью сердца  (ИБС), подвергающихся  коронарному шунтированию (КШ), и определить  ее  значимость  в развитии  послеоперационной  фибрилляции предсердий (ПОФП).</p></sec><sec><title>Материал  и методы</title><p>Материал  и методы. Обследовано 96 пациентов  с ИБС, поступивших для проведения  КШ. Больные были распределены на 2 группы: 1 группа — без ПОФП  (67  пациентов,   80,6%   мужчин,  средний   возраст   57,9±7,3   лет), 2 группа — с впервые возникшей ФП в раннем периоде КШ (29 пациентов, 86% мужчин, средний возраст  64,0±8,4 лет).</p></sec><sec><title>Результаты</title><p>Результаты. За период наблюдения ПОФП возникла в 30,2% случаев, в среднем на 4,9±3,8 сутки после операции. При сравнении с 1 группой уровень СОД оказался   выше  среди   пациентов   2  группы  (2589,8±1999,3  ед./г   против 1572,8±1275,2 ед./г,   р=0,034).  При этом  пациенты  2  группы были  старше в среднем на 4 года (64,0±8,4 против 57,9±7,3  лет, р=0,048), имели большую длительность кардиоваскулярной патологии (86,9±76,1 мес. против 44,3±38,4 мес.,  р=0,002). У больных с ПОФП чаще встречался  III функциональный класс (ФК) стенокардии (72,4% против 47,8%, р=0,028) и III ФК  хронической сердечной недостаточности  (38,0% против 7,5%, р=0,006), отмечался  больший размер  левого  предсердия (ЛП) при сравнении  с  1 группой (43,5±4,1  против 37,9±3,4 мм, р&lt;0,001).</p><p>После выполнения многофакторного анализа предсказательная ценность сохранилась  для  следующих параметров: размера  ЛП более  41 мм — 5,1 (95% ДИ, 2,1-9,8,  р=0,0005),  СОД более  2948 ед./г  — 4,4 (95% ДИ, 1,1-8,9, р=0,04).</p></sec><sec><title>Заключение</title><p>Заключение. Проведенное  исследование продемонстрировало, что операция КШ сопровождается активацией  окислительного  стресса, что приводит к снижению концентрации супероксиддисмутазы, вероятно, за счет ее потребления. Однако среди больных с ПОФП отмечается  более выраженная активность фермента.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To evaluate the level of superoxide dismutase (SOD) in coronary heart disease (CHD) patients underwent coronary bypass  (CBG), and to estimate  its importance in development of post-surgery atrial fibrillation (PSAF).</p></sec><sec><title>Material and methods</title><p>Material and methods. Totally, 96 patients studied,  with CHD, admitted for CBG. Patients were selected to 2 groups: 1 group — non-PSAF (67 patients, 80,6% males, mean age 57,9±7,3  y.o.), 2 group — with first time AF in early period of CBG (29 patients,  86% males, mean age 64,0±8,4 y.o.).</p></sec><sec><title>Results</title><p>Results. During study period PSAF developed  in 30,2% cases, mean on 4,9±3,8 day after surgery.  Comparing  with group  1, level of SOD was higher in group  2 patients (2589,8±1999,3 U/g vs 1572,8±1275,2 U/g, р=0,034). Patients of group 2 were  older  4 years  in average  (64,0±8,4  vs 57,9±7,3  y., р=0,048),  had  longer duration of cardiovascular pathology (86,9±76,1 months vs 44,3±38,4 m., р=0,002). Patients with PSAF had III functional class of angina (72,4% vs 47,8%, р=0,028) and III functional class of congestive  heart failure (38,0% vs 7,5%, р=0,006), they had larger left atrium (43,5±4,1 mm vs 37,9±3,4 mm, р&lt;0,001).</p><p>After multifactorial analysis, predictive value remained  for the following: left atrium larger than 41 mm — 5,1 (95% CI, 2,1-9,8, р=0,0005), SOD more than 2948 U/g — 4,4 (95% CI, 1,1-8,9, р=0,04).</p></sec><sec><title>Conclusion</title><p>Conclusion. The study  showed  that  CBG operation  is followed by activation of oxidation stress which is followed by the decrease of SOD concentration, probably due to its consumption.  However, among patients with PSAF there is higher activity of this enzyme.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фибрилляция  предсердий</kwd><kwd>коронарное шунтирование</kwd><kwd>супероксиддисмутаза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>coronary bypass</kwd><kwd>superoxide dismutase</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Thorén E, Hellgren L, Jidéus L, et al. Prediction of postoperative atrial fibrillation in a large coronary artery bypass grafting cohort. Interact Cardiovasc Thorac Surg. 2012; 14(5): 588-93.</mixed-citation><mixed-citation xml:lang="en">Thorén E, Hellgren L, Jidéus L, et al. Prediction of postoperative atrial fibrillation in a large coronary artery bypass grafting cohort. Interact Cardiovasc Thorac Surg. 2012; 14(5): 588-93.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Oktay V, Baydar O, Sinan UY. The effect of oxidative stress related with ischemiareperfusion damage on the pathogenesis of atrial fibrillation developing after coronary artery bypass graft surgery. Arch Turk Soc Cardiol 2014; 42(5): 419-25.</mixed-citation><mixed-citation xml:lang="en">Oktay V, Baydar O, Sinan UY. The effect of oxidative stress related with ischemiareperfusion damage on the pathogenesis of atrial fibrillation developing after coronary artery bypass graft surgery. Arch Turk Soc Cardiol 2014; 42(5): 419-25.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">El-Chami MF, Kilgo PD, Elfstrom KM et al. Prediction of new onset atrial fibrillation after cardiac revascularization surgery. Am J Cardiol. 2012; 110(5): 649-54.</mixed-citation><mixed-citation xml:lang="en">El-Chami MF, Kilgo PD, Elfstrom KM et al. Prediction of new onset atrial fibrillation after cardiac revascularization surgery. Am J Cardiol. 2012; 110(5): 649-54.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil 2008; 15: 735-41.</mixed-citation><mixed-citation xml:lang="en">Elahi MM, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil 2008; 15: 735-41.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Oral H. Post-operative atrial fibrillation and oxidative stress: a novel causal mechanism or another biochemical epiphenom enon? J Am Coll Cardiol 2008; 51: 75-6.</mixed-citation><mixed-citation xml:lang="en">Oral H. Post-operative atrial fibrillation and oxidative stress: a novel causal mechanism or another biochemical epiphenom enon? J Am Coll Cardiol 2008; 51: 75-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Youn JY, Zhang J, Zhang Y, et al. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol 2013; 62: 72-9.</mixed-citation><mixed-citation xml:lang="en">Youn JY, Zhang J, Zhang Y, et al. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol 2013; 62: 72-9.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YM, Kattach H, Ratnatunga C, et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 68-74.</mixed-citation><mixed-citation xml:lang="en">Kim YM, Kattach H, Ratnatunga C, et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008; 51: 68-74.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Parsaee M, Moradi B, Esmaeilzadeh M, et al. New onset atrial fibrillation after coronary artery bypasses grafting; an evaluation of mechanical left atrial function. Arch Iran Med. 2014; 17(7): 501-6.</mixed-citation><mixed-citation xml:lang="en">Parsaee M, Moradi B, Esmaeilzadeh M, et al. New onset atrial fibrillation after coronary artery bypasses grafting; an evaluation of mechanical left atrial function. Arch Iran Med. 2014; 17(7): 501-6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jakubova M, Mitro P, Stancak B, et al. The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients. Interact Cardiovasc Thorac Surg 2012; 15: 1007-12.</mixed-citation><mixed-citation xml:lang="en">Jakubova M, Mitro P, Stancak B, et al. The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients. Interact Cardiovasc Thorac Surg 2012; 15: 1007-12.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Escola-Gil JC, Calpe-Berdiel L, Palomer X, et al. Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice. Front Biosci. 2006; 11: 1328-48.</mixed-citation><mixed-citation xml:lang="en">Escola-Gil JC, Calpe-Berdiel L, Palomer X, et al. Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice. Front Biosci. 2006; 11: 1328-48.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Montaigne D, Marechal X, Lefebvre P, et al. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops. J Am Coll Cardiol. 2013; 62(16): 1466-73.</mixed-citation><mixed-citation xml:lang="en">Montaigne D, Marechal X, Lefebvre P, et al. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops. J Am Coll Cardiol. 2013; 62(16): 1466-73.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ramlawi B, Otu H, Mieno S, et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007; 84: 1166-73.</mixed-citation><mixed-citation xml:lang="en">Ramlawi B, Otu H, Mieno S, et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007; 84: 1166-73.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
